Regenerative Medicine for Joint Hypermobility and Instability

NCT07688096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Ehlers-Danlos Syndrome Hypermobility Type (hEDS)
Ehlers-Danlos Syndrome (EDS)
Joint Hypermobility
Joint Instability
Hypermobility Spectrum Disorder
Chronic Pain Syndrome
Musculoskeletal Pain
Sprain
Subluxation
Dislocation
Craniocervical Disfunction

Interventions

DRUG: Dextrose 20% Prolotherapy
BIOLOGICAL: Autologous Platelet-Rich Plasma
DRUG: Doxycycline Hyclate Injectable (Investigational)
DEVICE: Visco-3 Sodium Hyaluronate Viscosupplementation

Sponsor

Manhattan Pain Medicine, PLLC